Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults.
BACKGROUND
The optimal nutritional approach for the prevention of cardiovascular disease among obese persons remains a topic of intense controversy. Available approaches range from conventional low-fat to very-low-carbohydrate diets.


OBJECTIVE
The aim of this pilot study was to evaluate the efficacy of an ad libitum low-glycemic load diet, without strict limitation on carbohydrate intake, as an alternative to a conventional low-fat diet.


METHODS
A randomized controlled trial compared 2 dietary treatments in obese young adults (n = 23) over 12 mo. The experimental treatment emphasized ad libitum consumption of low-glycemic-index foods, with 45-50% of energy from carbohydrates and 30-35% from fat. The conventional treatment was restricted in energy (250-500 kcal/d deficit) and fat (<30% of energy), with 55-60% of energy from carbohydrate. We compared changes in study outcomes by repeated-measures analysis of log-transformed data and expressed the results as mean percentage change.


RESULTS
Body weight decreased significantly over a 6-mo intensive intervention in both the experimental and conventional diet groups (-8.4% and -7.8%, respectively) and remained below baseline at 12 mo (-7.8% and -6.1%, respectively). The experimental diet group showed a significantly greater mean decline in plasma triacylglycerols than did the conventional diet group (-37.2% and -19.1%, respectively; P = 0.005). Mean plasminogen activator inhibitor 1 concentrations decreased (-39.0%) in the experimental diet group but increased (33.1%) in the conventional diet group (P = 0.004). Changes in cholesterol concentrations, blood pressure, and insulin sensitivity did not differ significantly between the groups.


CONCLUSIONS
An ad libitum low-glycemic load diet may be more efficacious than a conventional, energy-restricted, low-fat diet in reducing cardiovascular disease risk.
Ebbeling
Cara B
CB
Division of Endocrinology, Department of Medicine, Children's Hospital, Boston, MA 02115, USA.
Leidig
Michael M
MM
Sinclair
Kelly B
KB
Seger-Shippee
Linda G
LG
Feldman
Henry A
HA
Ludwig
David S
DS
D000328:Adult; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D004040:Dietary Carbohydrates / Q000008:administration & dosage*; D004041:Dietary Fats / Q000008:administration & dosage*; D015444:Exercise; D005260:Female; D038321:Glycemic Index; D006801:Humans; D008297:Male; D009765:Obesity / Q000097:blood / Q000150:complications / Q000178:diet therapy*; D012307:Risk Factors
D004040:Dietary Carbohydrates; D004041:Dietary Fats; D002784:Cholesterol